- Evaluation of new agents in the treatment of Waldenstrom's macroglobulinemia (WM) and Multiple myeloma.
- In particular, I am interested in evaluating new targeted biological agents and autologous transplantation approaches for plasma cell and mature B-cell disorders, such as WM. As well, I am active in developing a uniform approach to fatigue and anemia in myeloma with a focus on disease-specific exercise programs.
- Medical education in hematology
- I am interested in the evaluation of time management skills within the CanMEDS roles in hematology training and the use of handheld personal devices (PDA) for clinical training.
Christine I Chen, MHPE, MD, FRCPC
Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre